TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
UroMedical Väst AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
69,294
|
59,387
|
58,836 |
Financial expenses |
422
|
4,996
|
1,495 |
Earnings before taxes |
11,113
|
-419
|
4,501 |
EBITDA |
12,083
|
5,667
|
6,935 |
Total assets |
22,178
|
29,161
|
27,984 |
Current assets |
9,570
|
17,397
|
14,037 |
Current liabilities |
7,308
|
15,275
|
12,575 |
Equity capital |
14,024
|
13,096
|
14,822 |
- share capital |
51
|
47
|
49 |
Employees (average) |
22
![]() |
22
|
19 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.2%
|
44.9%
|
53.0% |
Turnover per employee |
3,150
|
2,699
|
3,097 |
Profit as a percentage of turnover |
16.0%
|
-0.7%
|
7.7% |
Return on assets (ROA) |
52.0%
|
15.7%
|
21.4% |
Current ratio |
131.0%
|
113.9%
|
111.6% |
Return on equity (ROE) |
79.2%
|
-3.2%
|
30.4% |
Change turnover |
5,693
|
2,319
|
4,995 |
Change turnover % |
9%
|
4%
|
9% |
Chg. No. of employees |
0
|
3
|
4 |
Chg. No. of employees % |
0%
|
16%
|
27% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.